Cardiac troponin-I and risk of heart failure: a community-based cohort study.
about
Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure SectionWeight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.Chronic heart failure: contemporary diagnosis and managementHigh-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomographyHigh sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study.Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathiesSensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study.Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisitedAssociation of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Cardiovascular biomarkers and their utility in the older adult.Biomarkers: optimizing treatment guidance in heart failure.Prevention of heart failure in the elderly: when, where and how to begin?The use of biomarkers in the patient with heart failure.Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer.Current applications of biomarkers in cardiomyopathies.A window into your heart: taking cardiac troponin to the next level.An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography.Troponin and heart failure: an early warning system worth listening to?Autoantibodies against cardiac troponin I in patients with congestive heart failure.SYKT Alleviates Doxorubicin-Induced Cardiotoxicity via Modulating ROS-Mediated p53 and MAPK Signal Pathways
P2860
Q28269814-74CA0244-1488-4BC9-BD89-CEBED99DE21AQ33601449-E78C17FD-F72D-4734-890A-152E07ACB32DQ33620431-77965BC7-E9A2-4516-B8CC-EFBA6187332DQ33821446-66D19091-1F16-4365-8B9C-2690133AF6A8Q33951088-1F464A65-A005-47B1-9C9F-E49C6CCB0B96Q34914470-4B556D7A-D079-438A-9379-CF4485009799Q35130613-FB7D8812-6F62-4232-A419-6E46E014EA6CQ35138063-A4A12DEB-CC28-4A84-8D2A-5BB88CE8755AQ36574151-DF18E2E5-26CA-4061-BDC3-BDE68C727F5CQ37681556-F4889DFA-1F3B-4655-8208-3F0C1132529AQ37691417-46B59F3C-F498-49A6-A04B-8C497ED0ABF7Q37903747-33327AAB-E668-4B48-9AAA-85519B4D9B65Q37978190-BF7777F3-B91F-43D8-9759-575FB518191FQ38104269-1B030D28-5034-4664-B5F9-F99C11285F2CQ38518602-2860F697-EDE9-4866-AAC4-2ABC3FF97788Q38536678-0E2C66FC-4295-4870-8C87-F67FD6DDCB1DQ39809276-450D3217-1F75-4EFD-8B38-836B2A91441BQ40160496-68A5226B-9765-4888-84FF-F85F06EB5495Q43964694-700A8DFF-463D-4D24-B7A6-4C8BF6C52389Q48180360-5DF5B1A0-4584-474E-BA4D-519606190839Q58702069-6507039F-22BA-42B0-8517-F7F6100C564C
P2860
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@en
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@nl
type
label
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@en
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@nl
prefLabel
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@en
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@nl
P50
P356
P1476
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
@en
P2093
Johan Arnlöv
P304
P356
10.1093/EURHEARTJ/EHP047
P577
2009-03-04T00:00:00Z